TABLE 1
FROM:
Bupropion for the Treatment of Methamphetamine Dependence
Ahmed M Elkashef, Richard A Rawson, Ann L Anderson, Shou-Hua Li, Tyson Holmes, Edwina V Smith, Nora Chiang, Roberta Kahn, Frank Vocci, Walter Ling, Valerie J Pearce, Michael McCann, Jan Campbell, Charles Gorodetzky, William Haning, Barry Carlton, Joseph Mawhinney and Dennis Weis
BACK TO ARTICLETable 1. Baseline Characteristics of Randomized Participants for the Bupropion-Methamphetamine Study
| Bupropion | Placebo | ||||
|---|---|---|---|---|---|
| N=79 | N=72 | p-values | |||
| Age (years) | 36.2 | (9.2)a | 35.7 | (8.4) | 0.72 |
| Gender | 0.33 | ||||
| Male | 50 | (63%) | 51 | (71%) | |
| Female | 29 | (37%) | 21 | (29%) | |
| Race | 0.93 | ||||
| White, not Hispanic | 59 | (75%) | 53 | (74%) | |
| Hispanic or Latino | 5 | (6%) | 5 | (7%) | |
| African American or Black | 2 | (3%) | 2 | (3%) | |
| Asian or Pacific Islander | 11 | (14%) | 10 | (14%) | |
| American Indian or Alaska | 1 | (1%) | 0 | (0%) | |
| Other | 1 | (1%) | 2 | (3%) | |
| Years of education | 12.6 | (1.9)a | 12.4 | (1.7) | 0.48 |
| Days of methamphetamine use in last 30 days | 0.66 | ||||
 18 | 36 | (46%) | 35 | (49%) | |
| >18 | 43 | (54%) | 37 | (51%) | |
| Lifetime years of methamphetamine use | 10.42 | (7.59)a | 9.97 | (6.10) | 0.69 |
| Route of lifetime methamphetamine use | 0.66 | ||||
| Nasal | 15 | (19%) | 10 | (14%) | |
| Smoking | 49 | (62%) | 49 | (68%) | |
| Injection | 15 | (19%) | 13 | (18%) | |
| Baseline period urine methamphetamine screens (% positive) | 82.9% | 80.3% | |||
| Depression (HAM-D score) | 0.78 | ||||
| 12 | 64 | (81%) | 57 | (79%) | |
| >12 | 15 | (19%) | 15 | (21%) | |
| Adult ADHD | 0.03 | ||||
| No | 73 | (92%) | 58 | (81%) | |
| Yes | 6 | (8%) | 14 | (19%) | |
a Standard deviation.
